Financial statements Biomatgel
Balance sheet data of BIOMATGEL
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 16 042,35 | 109 977,35 | 402 334,76 | 560 336,47 | 904 671,15 | 802 954,63 |
| A. Fixed assets | - | 0,00 | 0,00 | 0,00 | 642 925,09 | 642 925,09 |
| B. Current assets | 16 042,35 | 109 977,35 | 402 334,76 | 560 336,47 | 261 746,06 | 160 029,54 |
| C. Share capital contributions (basic funds) | - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 16 042,35 | 109 977,35 | 402 334,76 | 560 336,47 | 904 671,15 | 802 954,63 |
| A. Equity | 15 213,85 | 107 556,50 | 353 026,35 | 397 405,06 | 618 608,79 | 579 119,07 |
| B. Liabilities and provisions for liabilities | 828,50 | 2 420,85 | 49 308,41 | 162 931,41 | 286 062,36 | 223 835,56 |
| I. Long-term liabilities | - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| II. Short-term liabilities | 828,50 | 2 420,85 | 49 308,41 | 162 931,41 | 176 457,85 | 11 559,18 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.